Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Cholangiocarcinoma is cancer that forms in the bile ducts, which are a series of thin tubes that go from the liver to the small intestine. Bile ducts carry a fluid called bile from the liver and gallbladder into the small intestine, where it helps digest the fats in food. Cholangiocarcinoma, also known as bile duct cancer, is an uncommon form of cancer that occurs mostly in people older than age 50.
Cancer that occurs in the parts of the bile ducts that are within the liver is called intrahepatic cholangiocarcinoma (ICC), also known as intrahepatic bile duct cancer. ICC is a rare disease and makes up about 10% of all cholangiocarcinoma. ICC is treated at Dana-Farber/Brigham and Women's Cancer Center's (DF/BWCC) Liver Cancer Center. Another more common form of bile duct cancer is extrahepatic cholangiocarcinoma, or biliary cancer, which is cancer occurring outside the liver. The Pancreas and Biliary Tumor Center at DF/BWCC treats patients with pancreatic and biliary disease.
Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. People who think they may be at risk should discuss this with their doctor.
Risk factors for intrahepatic cholangiocarcinoma include:
These and other signs and symptoms also may be caused by cholangiocarcinoma or by other conditions. Check with your doctor if you have any of the following:
Tests that examine the bile ducts and nearby organs are used to diagnose and stage intrahepatic cholangiocarcinoma. The following test and procedures may be used:
The Liver Cancer Center at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) has deep expertise in treating intrahepatic cholangiocarcinoma. The Center conducts crucial research and clinical trials to learn more about the disease and develop promising new treatments.
There are different types of treatment for patients with intrahepatic cholangiocarcinoma. Three types of standard treatment are used:
Learn more about the Liver Cancer Center, our approach to patient treatment and care, and our innovative research on intrahepatic cholangiocarcinoma.
New Patient Appointments